Tag #Breast Cancer

Showing 61 to 72 of 90 results

nbcnews.com

🌐 85% Global Worthiness

Feb 25, 16:13

Medicare Cuts Reimbursement for Breast Cancer Screenings, Raising Costs for Women

Medicare's 2024 decision to stop reimbursing for breast ultrasound screenings, even when diagnostic, is forcing many women to pay thousands of dollars out-of-pocket for necessary follow-up care after abnormal mammograms, impacting both Medicare and privately insured women, and potentially delaying c...

Medicare Cuts Reimbursement for Breast Cancer Screenings, Raising Costs for Women

Medicare's 2024 decision to stop reimbursing for breast ultrasound screenings, even when diagnostic, is forcing many women to pay thousands of dollars out-of-pocket for necessary follow-up care after abnormal mammograms, impacting both Medicare and privately insured women, and potentially delaying c...

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the cascading effects of Medicare's reimbursement decision on private insurers and the overall affordability of crucial breast cancer screenings?

The denial of reimbursement by Medicare for breast ultrasounds, even when used diagnostically following abnormal mammograms, is causing a cascade effect. Private insurers often mirror Medicare's coverage decisions, leading to widespread cost increases for patients. This trend is amplified by rising high-deductible insurance plans, pushing many women to forgo essential screenings due to unaffordable costs.

dailymail.co.uk

🌐 85% Global Worthiness

Feb 24, 19:09

UK Breast Cancer Deaths Projected to Soar by 42% by 2050

A World Health Organization study projects a 42 percent increase in UK breast cancer deaths by 2050, reaching 17,261, due to an aging population, unhealthy lifestyles, and mortality rates exceeding those in countries like the US and Sweden despite lower incidence rates.

UK Breast Cancer Deaths Projected to Soar by 42% by 2050

A World Health Organization study projects a 42 percent increase in UK breast cancer deaths by 2050, reaching 17,261, due to an aging population, unhealthy lifestyles, and mortality rates exceeding those in countries like the US and Sweden despite lower incidence rates.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the projected increases in breast cancer deaths in the UK by 2050, and what factors contribute to this rise?

Breast cancer deaths in the UK are projected to increase by over 40 percent by 2050, rising from 12,122 in 2022 to 17,261. This increase is attributed to a growing and aging population, coupled with unhealthy lifestyles. The UK's breast cancer death rate also exceeds that of the US.

dailymail.co.uk

🌐 85% Global Worthiness

Feb 17, 19:09

Bionic Breast Implant Trial Seeks to Restore Sensation After Mastectomy

A new 'bionic breast' implant is being trialled in the US to restore sensation lost after mastectomies, addressing the significant issue of numbness and pain experienced by many women post-surgery, with an initial trial of 8 patients.

Bionic Breast Implant Trial Seeks to Restore Sensation After Mastectomy

A new 'bionic breast' implant is being trialled in the US to restore sensation lost after mastectomies, addressing the significant issue of numbness and pain experienced by many women post-surgery, with an initial trial of 8 patients.

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the primary goal of the bionic breast trial and how will it impact breast cancer patients?

A new 'bionic breast' device is being trialled in the US, aiming to restore sensation lost during mastectomies. The implant uses sensors and electrodes to convert touch into electrical signals, perceived as feeling by the patient. This addresses the significant issue of numbness and pain affecting many mastectomy patients.

dailymail.co.uk

🌐 90% Global Worthiness

Feb 15, 04:08

Spiky Tumor Structures Identified as Key Driver of Cancer Metastasis

Scientists discovered that aggressive breast and melanoma tumors have spiky structures that facilitate cancer spread, potentially leading to new treatments that prevent metastasis by targeting these spikes.

Spiky Tumor Structures Identified as Key Driver of Cancer Metastasis

Scientists discovered that aggressive breast and melanoma tumors have spiky structures that facilitate cancer spread, potentially leading to new treatments that prevent metastasis by targeting these spikes.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How do the newly discovered spiky structures on aggressive breast tumors impact cancer metastasis and patient survival?

Aggressive breast tumors exhibit unique spiky structures, unlike less aggressive tumors. These spikes facilitate cancer cell travel to other organs, leading to metastasis and potentially terminal diagnoses. The discovery, based on analysis of 30 breast cancer and 65 melanoma patient samples, could enable earlier detection and targeted treatment.

npr.org

🌐 85% Global Worthiness

Feb 13, 07:09

Fertility-Sparing Treatments Offer Hope for Young Women with Breast Cancer

Improved breast cancer treatments are enabling young women to balance cancer treatment with fertility preservation, though challenges remain, as illustrated by Maggie Loucks' journey.

Fertility-Sparing Treatments Offer Hope for Young Women with Breast Cancer

Improved breast cancer treatments are enabling young women to balance cancer treatment with fertility preservation, though challenges remain, as illustrated by Maggie Loucks' journey.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How are advancements in breast cancer treatment impacting fertility options for young adult women diagnosed with hormone-receptive breast cancer?

Improved treatments for hormone-receptive breast cancer, a type increasingly affecting young women, allow for fertility preservation in many cases. A study showed that pausing treatment for about two years to have a baby, then resuming, was feasible and safe for a majority of women. This offers young women diagnosed with breast cancer new options for balancing cancer treatment with their desire to have children.

lemonde.fr

🌐 85% Global Worthiness

Feb 9, 07:06

France's High Breast Cancer Rate: Beyond Detection

France reports the world's highest breast cancer incidence in 2022, with mortality exceeding comparable nations by 10-50%, despite advanced healthcare; a 50% increase in cases since 1990 surpasses population growth, indicating additional risk factors beyond individual lifestyle choices.

France's High Breast Cancer Rate: Beyond Detection

France reports the world's highest breast cancer incidence in 2022, with mortality exceeding comparable nations by 10-50%, despite advanced healthcare; a 50% increase in cases since 1990 surpasses population growth, indicating additional risk factors beyond individual lifestyle choices.

Progress

56% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the potential long-term implications of France's high breast cancer incidence, and what public health strategies could effectively address this challenge?

The 50% increase in French breast cancer cases between 1990 and 2023, exceeding population growth, points to environmental or lifestyle factors not fully explained by individual risk factors. Further research is crucial to identify these factors and implement effective preventative measures.

sante.lefigaro.fr

🌐 85% Global Worthiness

Feb 24, 22:09

Global Rise in Breast Cancer Cases and Disparities in Mortality Rates

A global study reveals a rising incidence of breast cancer, with over 60,000 new cases annually in France and 2.3 million globally, resulting in 670,000 deaths; disparities exist between high-income countries with better access to care and low-income countries facing higher mortality rates due to la...

Global Rise in Breast Cancer Cases and Disparities in Mortality Rates

A global study reveals a rising incidence of breast cancer, with over 60,000 new cases annually in France and 2.3 million globally, resulting in 670,000 deaths; disparities exist between high-income countries with better access to care and low-income countries facing higher mortality rates due to la...

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate global impacts of the rising incidence of breast cancer?

Breast cancer is the most frequent cancer and leading cause of death among women in France, with over 60,000 new cases annually. A global study reveals a worldwide increase, with one in 20 women receiving a diagnosis and one in 70 dying from it; in France, these probabilities are one in nine and one in 59, respectively.

dutchnews.nl

🌐 85% Global Worthiness

Feb 18, 16:10

Dutch Insurers Limit Coverage of Two Breast Cancer Drugs

Dutch health insurers ended full coverage for two expensive breast cancer drugs (ribociclib and abemaciclib), impacting 2,000 women, due to high costs and a price negotiation failure with drug manufacturers, despite oncologists' concerns about differing drug effectiveness and side effects.

Dutch Insurers Limit Coverage of Two Breast Cancer Drugs

Dutch health insurers ended full coverage for two expensive breast cancer drugs (ribociclib and abemaciclib), impacting 2,000 women, due to high costs and a price negotiation failure with drug manufacturers, despite oncologists' concerns about differing drug effectiveness and side effects.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

Why do oncologists and patient advocacy groups oppose the insurers' decision to limit coverage of the breast cancer drugs?

The insurers' decision is based on the assertion that the three drugs are interchangeable, a claim disputed by oncologists and at least one pharmaceutical company currently suing the insurers. This is despite evidence of differing effectiveness and side effects. Patient organizations report concerns about patients being switched to alternative drugs solely due to cost.

theguardian.com

🌐 75% Global Worthiness

Feb 17, 04:10

NHS Launches First Breast Cancer Screening Awareness Campaign

The NHS England launched its first breast cancer screening awareness campaign to increase participation, which is currently at 64.6%, aiming to reach 80% by 2025-26 to detect thousands more cancers at an early stage and save lives.

NHS Launches First Breast Cancer Screening Awareness Campaign

The NHS England launched its first breast cancer screening awareness campaign to increase participation, which is currently at 64.6%, aiming to reach 80% by 2025-26 to detect thousands more cancers at an early stage and save lives.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the primary goal of the NHS's new breast cancer screening campaign, and what are its immediate projected impacts on public health?

The NHS in England launched its first breast cancer screening awareness campaign, aiming to increase participation through TV, radio, and online advertisements. The campaign highlights that the program prevents 1,300 deaths annually and detected 18,942 cancers last year alone, emphasizing early detection's importance for survival rates. Uptake is currently lower than pre-pandemic levels, at 64.6% in 2022-23.

repubblica.it

🌐 85% Global Worthiness

Feb 14, 19:09

Inavolisib Improves Outcomes in Pik3ca-Mutated Breast Cancer

A clinical trial (Inavo120) demonstrated that inavolisib, combined with palbociclib and fulvestrant, significantly improved progression-free and overall survival in 325 patients with hormone receptor-positive, HER2-negative, Pik3ca-mutated breast cancer compared to the standard therapy; the FDA appr...

Inavolisib Improves Outcomes in Pik3ca-Mutated Breast Cancer

A clinical trial (Inavo120) demonstrated that inavolisib, combined with palbociclib and fulvestrant, significantly improved progression-free and overall survival in 325 patients with hormone receptor-positive, HER2-negative, Pik3ca-mutated breast cancer compared to the standard therapy; the FDA appr...

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the clinical significance of inavolisib's efficacy in treating Pik3ca-mutated breast cancer?

A new oral targeted therapy, inavolisib, significantly improves outcomes for patients with locally advanced or metastatic breast cancer harboring the common Pik3ca gene mutation (present in ~40% of cases). The Inavo120 clinical trial showed that combining inavolisib with palbociclib and fulvestrant substantially increased both progression-free survival and overall survival compared to palbociclib and fulvestrant alone. The FDA has already approved this combination.

npr.org

🌐 85% Global Worthiness

Feb 12, 13:17

Cancer Treatment Advancements Allow Fertility Preservation, But Raise New Challenges

Maggie Loucks, diagnosed with HER2-positive breast cancer at 28, chose a less aggressive chemotherapy regimen to preserve fertility, highlighting advancements in cancer treatment that prioritize quality of life alongside cancer survival, but also facing subsequent fertility challenges.

Cancer Treatment Advancements Allow Fertility Preservation, But Raise New Challenges

Maggie Loucks, diagnosed with HER2-positive breast cancer at 28, chose a less aggressive chemotherapy regimen to preserve fertility, highlighting advancements in cancer treatment that prioritize quality of life alongside cancer survival, but also facing subsequent fertility challenges.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the long-term implications of prioritizing fertility preservation in breast cancer treatment for young women, and what are the potential trade-offs?

Loucks's case demonstrates the growing importance of psychosocial outcomes in cancer treatment. While initially focused on fertility preservation, her experience reveals the emotional toll of treatment and subsequent fertility struggles. The long-term impact of choosing less aggressive chemotherapy on cancer recurrence remains a concern, but her experience underscores the need for individualized treatment plans.

dailymail.co.uk

🌐 75% Global Worthiness

Feb 4, 16:11

Missed Cancer Diagnosis Highlights Need for Ultrasound in Dense Breasts

TV presenter Julia Bradbury's breast cancer was missed twice due to dense breast tissue; an ultrasound finally detected a 6cm tumor during a third consultation, prompting reflection on the importance of alternative imaging for dense breasts and lifestyle changes in cancer prevention and recovery.

Missed Cancer Diagnosis Highlights Need for Ultrasound in Dense Breasts

TV presenter Julia Bradbury's breast cancer was missed twice due to dense breast tissue; an ultrasound finally detected a 6cm tumor during a third consultation, prompting reflection on the importance of alternative imaging for dense breasts and lifestyle changes in cancer prevention and recovery.

Progress

28% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What crucial factor delayed Julia Bradbury's breast cancer diagnosis, and what are the immediate implications for women with similar breast density?

Julia Bradbury, a 54-year-old TV presenter, was diagnosed with breast cancer in 2021 after two mammograms failed to detect it due to dense breast tissue. An ultrasound, performed before a scheduled year-long wait for another mammogram, finally revealed a 6cm tumor.

Showing 61 to 72 of 90 results